PACANALOTAMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:02:17 GMT 2023` Edited by `admin` on `Sat Dec 16 14:02:17 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	SCFV
Sequence Type	COMPLETE
Record UNII	102VUR9WQE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PACANALOTAMAB

Official Name

English

BI-836909

Code

English

AMG-420

Code

English

BISPECIFIC T-CELL ENGAGER ANTIBODY WITH A SINGLE CHAIN FC MOIETY THAT BINDS TO B CELL MATURATION ANTIGEN SURFACE RECEPTOR AND CD3

Common Name

English

IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, CD269 ANTIGEN)) TNR17 AND ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (T-CELL SURFACE ANTIGEN T3/LEU-4 EPSI

Common Name

English

AMG420

Code

English

pacanalotamab [INN]

Common Name

English

IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENSTNFRSF17 (TNF RECEPTOR SUPERFAMILY MEMBER 17, TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, BCM, TNFRSF13A, CD269)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON)), MONOCLON

Common Name

English

Pacanalotamab [WHO-DD]

Common Name

English

PACANALOTAMAB [USAN]

Common Name

English

IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN MONOCLONAL BRA-KAN 1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMA

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

644818